Welcome to the e-CCO Library!

P282: Does colonoscopy alter the post-procedural fecal calprotectin results in Crohn's disease patients with ileocecal resection?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Erzin Y., Demir N., Bozcan S., Yıldırım S., Hatemi I., Celik A.F.

Created: Wednesday, 20 February 2019, 10:36 AM
P282: High plasma oncostatin-M predicts non-response to tumour necrosis factor-alpha antagonists in inflammatory bowel disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Guo, A.(1);Ross, C.(2);Chande, N.(3);Gregor, J.(3);Ponich, T.(3);Beaton, M.(3);Khanna, R.(3);Kim, R.(4);Wilson, A.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P282: Influence of phenotype at diagnosis and of other potential prognostic factors on the prognosis of Crohn’s Disease in Chinese population
Year: 2022
Source: ECCO'22
Authors: Xiao, Z.(1,2);Wu, L.(1);Cao, Q.(1);
Created: Friday, 11 February 2022, 3:52 PM
P282: Isolated colonic Crohn's disease and extensive ulcerative colitis: is there a reel difference?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ben Safta, N.(1)*;Ben Mustpha, N.(1);Khemiri, W.(1);Serghini, M.(1);Laabidi, S.(1);Fekih, M.(1);Labidi, A.(1);Boubaker, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P282: The long-term effect of biologics in newborns
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

B. Truta*, J. Canner, J. Efron, B. Safar

Created: Friday, 22 February 2019, 9:49 AM
P283 Patient-reported symptoms over a period of 14 days reliably predict endoscopic and histological disease activity in ulcerative colitis (UC)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Kormilitzin1, A.J. Walsh2, L. Matini2, R. Kantschuster2, M. Lepetyukh3, J. Wilson2, O. Brain2, R. Palmer2, T. Ambrose2, J. Satsangi2, S.P.L. Travis2

Created: Thursday, 30 January 2020, 10:12 AM
P283: Awareness and perceptions of colorectal cancer risk and screening in Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Liu, E.(1)*;Erande, A.(2);McLaughlin, J.(3);Limdi, J.K.(1);
Created: Friday, 14 July 2023, 11:05 AM
P283: Bowel urgency in patients with moderate to severe ulcerative colitis: prevalence and correlation with clinical outcomes, biomarker levels, and health-related quality of life from U-ACHIEVE, a Phase 2b study of upadacitinib
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Ghosh*1, E. Louis2, E. V. Loftus Jr3, W. Reinisch4, F. Cataldi5, W. Zhou5, W-J. Lee5, J. Panes6

Created: Friday, 22 February 2019, 9:41 AM
P283: Decrease in bowel wall thickness at intestinal ultrasound accurately detects early endoscopic remission and improvement in ulcerative colitis patients on tofacitinib: a longitudinal prospective cohort study.
Year: 2021
Source: ECCO'21 Virtual
Authors: de Voogd, F.(1);Van Wassenaer, E.(2);Mookhoek, A.(3);Bots, S.(1);Van Gennep, S.(1);Duijvestein, M.(1);Ponsioen, C.(1);Löwenberg, M.(1);D'Haens, G.(1);Gecse, K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P283: Development, validation and clinical application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease: IBD-KNOW
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

H. Yoon*1, S.-K. Yang2, H. So2, K. E. Lee3, S. H. Park2, S.-A. Jung3, C. M. Shin1, Y. S. Park1, N. Kim1, D. H. Lee1

Created: Friday, 22 February 2019, 9:49 AM
P283: Infliximab re-challenge: could it be an option in refractory IBD patients?
Year: 2022
Source: ECCO'22
Authors: Truyens, M.(1);Pijoan Comas, E.(2);Glorieus, E.(1);Geldof, J.(1);Lobatón Ortega, T.(1);
Created: Friday, 11 February 2022, 3:52 PM
P283: Predicting outcomes in paediatric Crohn’s disease: A systematic review
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Ricciuto1*, M. Aardoom2, E. Orlanski-Meyer3, N. Carman4, D. Turner3, L. de Ridder2, A. Griffiths1

Created: Thursday, 21 February 2019, 9:14 AM
P283: Quantum blue® adalimumab: development of the first point of care rapid test for therapeutic drug monitoring of serum adalimumab levels
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bantleon F.I., Kräuchi S., Schuster T.B., Schneider M., Abel A.

Created: Wednesday, 20 February 2019, 10:36 AM
P284 Disentangling fibromyalgia from spondyloarthopathy in the patient with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Variola1, E. Bertolini2, M. Di Ruscio1, F. Vernia3, A. Geccherle1, M. Beltrami2, I. Tinazzi4, P. Macchioni5

Created: Thursday, 30 January 2020, 10:12 AM
P284: Assessing Patient Experience in an Inflammatory Bowel Disease service. Can we measure an effect from socioeconomic deprivation – experience from the AWARE-IBD programme?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sheldon, E.(1)*;Roman, S.(2);Bursnall, M.(3);Hawkins, R.(4);Lobo, A.(2);Hind, D.(4);Randall, K.(5);Wakeman, R.(6);Ainley, R.(7);
Created: Friday, 14 July 2023, 11:05 AM
P284: Assessment of prothrombotic tendency in IBD pregnant patients and its associated risk factors
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Rottenstreich1, M. Diminsky2, S. Grisaru-Granovsky3, M. Tali3, B. Roth5, G. Spectre6, J. Kalish5, G. Abitbol8, A. Hoyda8, E. Goldin10, A. Bar-Gil Shitrit*8

Created: Friday, 22 February 2019, 9:41 AM
P284: Drug survival and remission rates in ustekinumab treated ulcerative colitis: Results from the Swedish Inflammatory Bowel Disease register (SWIBREG)
Year: 2021
Source: ECCO'21 Virtual
Authors: Thunberg, J.(1);Björkqvist, O.(1);Olén, O.(2);Ludvigsson, J.F.(3);Eriksson, C.(1);Halfvarson, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P284: Jejunal Crohn’s disease: characteristics, detection rate, outcome, and need of immunomodulators in a retrospective single-centre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Ruffa1, C. Petruzziello2, E. Angelucci3, G. Sica4, S. Onali3, A. Rossi2, E. Calabrese2, E. Lolli3, F. Pallone3, L. Biancone*5

Created: Friday, 22 February 2019, 9:49 AM
P284: Prophylactic medication for the prevention of endoscopic recurrence after ileocolonic resection in Crohn’s disease: a prospective study based on clinical risk stratification
Year: 2022
Source: ECCO'22
Authors: Arkenbosch , J.H.(1);Beelen, E.M.J.(1);Dijkstra, G.(2);Romberg-Camps, M.(3);Duijvestein, M.(4);Hoentjen, F.(5);van der Marel, S.(6); Maljaars, P.W.J.(7);Jansen, S.(8);de Boer, N.K.(9);West, R.(10);Horjus, C.(11); Stassen, L.P.S.(12);van Schaik , F.(13);van Ruler, O.(14); Jharap, B.J.H.(15);Erler, N.E.(16);Doukas , M.(17); Ooms, A.H.A.G.(18);Kats-Ugurlu, G.(19);van der Woude, J.(1);De Vries, A.C.(1);
Created: Friday, 11 February 2022, 3:52 PM